著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
HATA A,Erlotinib after gefitinib failure in relapsed non-small cell lung cancer : clinical benefit with optimal patient selection,Lung Cancer,,,2011,74,,268-273,https://cir.nii.ac.jp/crid/1572543026259472128,